4min chapter

New Books in Finance cover image

Victor Roy, "Capitalizing a Cure: How Finance Controls the Price and Value of Medicines" (U California Press, 2023)

New Books in Finance

CHAPTER

How Pharmaceutical Companies Shaped Expectations About the Future?

Gilead paid $11 billion to buy the suboscopy or intellectual property that was already in phase two trials from another company, in this case, pharmacist. The pharmaceutical industry can maintain a market where they have pretty unfettered pricing power,. That will then allow them to generate large valuations on intellectual property. And so part of this is by actually making sure that legislation that would potentially create more pressure on actually having to negotiate drug prices and other kinds of policy moves that might threaten pricing power are kind of curbed or that they don't come about.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode